225 related articles for article (PubMed ID: 33180376)
1. Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics.
Jabbal S; Kuo CR; Lipworth B
Clin Exp Allergy; 2020 Oct; 50(10):1140-1147. PubMed ID: 33180376
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.
Miravitlles M; Urrutia G; Mathioudakis AG; Ancochea J
Respir Res; 2017 Nov; 18(1):196. PubMed ID: 29178871
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol.
Moretz C; Bengtson LG; Sharpsten L; Koep E; Le L; Tong J; Stanford RH; Hahn B; Ray R
Int J Chron Obstruct Pulmon Dis; 2019; 14():2047-2060. PubMed ID: 31564852
[TBL] [Abstract][Full Text] [Related]
4. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
Kew KM; Evans DJ; Allison DE; Boyter AC
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
[TBL] [Abstract][Full Text] [Related]
5. Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy.
Palli SR; Frazer M; DuCharme M; Buikema AR; Anderson AJ; Franchino-Elder J
J Manag Care Spec Pharm; 2020 Oct; 26(10):1363-1374. PubMed ID: 32678719
[TBL] [Abstract][Full Text] [Related]
6. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
Manoharan A; Morrison AE; Lipworth BJ
Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
[TBL] [Abstract][Full Text] [Related]
7. The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.
Dean J; Panainte C; Khan N; Singh D
Respir Res; 2020 Dec; 21(1):323. PubMed ID: 33298062
[TBL] [Abstract][Full Text] [Related]
8. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry.
Yamaguchi M; Niimi A; Ueda T; Takemura M; Matsuoka H; Jinnai M; Otsuka K; Oguma T; Takeda T; Ito I; Matsumoto H; Hirai T; Chin K; Mishima M
Pulm Pharmacol Ther; 2009 Aug; 22(4):326-32. PubMed ID: 19489132
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease.
Muraki M; Kunita Y; Shirahase K; Yamazaki R; Hanada S; Sawaguchi H; Tohda Y
BMC Pulm Med; 2021 Jan; 21(1):26. PubMed ID: 33441146
[TBL] [Abstract][Full Text] [Related]
10. Is Gly16Arg β2 Receptor Polymorphism Related to Impulse Oscillometry in a Real-Life Asthma Clinic Setting?
Jabbal S; Manoharan A; Lipworth J; Anderson W; Short P; Lipworth B
Lung; 2016 Apr; 194(2):267-71. PubMed ID: 26880163
[TBL] [Abstract][Full Text] [Related]
11. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma.
Evans DJ; Kew KM; Anderson DE; Boyter AC
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD011437. PubMed ID: 26196545
[TBL] [Abstract][Full Text] [Related]
12. The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.
Lai CC; Chen CH; Lin CYH; Wang CY; Wang YH
Int J Chron Obstruct Pulmon Dis; 2019; 14():1539-1548. PubMed ID: 31371939
[TBL] [Abstract][Full Text] [Related]
13. A Single Institution Retrospective Study of the Clinical Efficacy of Tiotropium Respimat in Never-Smoking Elderly Asthmatics with Irreversible Airflow Limitation.
Hara J; Kasahara K; Ohkura N; Yamamura K; Sakai T; Abo M; Ogawa N; Saeki K; Koba H; Watanabe S; Uchida Y; Tambo Y; Sone T; Kimura H
Drug Res (Stuttg); 2019 Apr; 69(4):211-217. PubMed ID: 30193393
[TBL] [Abstract][Full Text] [Related]
14. Assessment of physical functioning and handling of tiotropium/olodaterol Respimat
Steinmetz KO; Abenhardt B; Pabst S; Hänsel M; Kondla A; Bayer V; Buhl R
Int J Chron Obstruct Pulmon Dis; 2019; 14():1441-1453. PubMed ID: 31308649
[TBL] [Abstract][Full Text] [Related]
15. A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT
Buhl R; Dreher M; Korn S; Taube C; Stock C; Zehendner CM; Kondla A; Vogelmeier CF
Int J Chron Obstruct Pulmon Dis; 2020; 15():2601-2608. PubMed ID: 33122898
[TBL] [Abstract][Full Text] [Related]
16. Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma: A Systematic Review and Meta-analysis.
Kim LHY; Saleh C; Whalen-Browne A; O'Byrne PM; Chu DK
JAMA; 2021 Jun; 325(24):2466-2479. PubMed ID: 34009257
[TBL] [Abstract][Full Text] [Related]
17. Assessment of spirometry and impulse oscillometry in relation to asthma control.
Manoharan A; Anderson WJ; Lipworth J; Lipworth BJ
Lung; 2015 Feb; 193(1):47-51. PubMed ID: 25516285
[TBL] [Abstract][Full Text] [Related]
18. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
Rodrigo GJ; Price D; Anzueto A; Singh D; Altman P; Bader G; Patalano F; Fogel R; Kostikas K
Int J Chron Obstruct Pulmon Dis; 2017; 12():907-922. PubMed ID: 28360514
[TBL] [Abstract][Full Text] [Related]
19. Are we overlooking persistent small airways dysfunction in community-managed asthma?
Anderson WJ; Zajda E; Lipworth BJ
Ann Allergy Asthma Immunol; 2012 Sep; 109(3):185-189.e2. PubMed ID: 22920073
[TBL] [Abstract][Full Text] [Related]
20. The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects.
Derom E; Brusselle GG; Joos GF
Ther Adv Respir Dis; 2019; 13():1753466619843426. PubMed ID: 31002020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
